Drug intelligence / Profile preview

heat shock protein preparation

Development stage: Unknown
Lead developer: Foshan Rexiu Biotechnology
Modality: Recombinant Proteins and Enzymes

Overview

A heat shock protein preparation extracted from placenta, currently under investigation for the treatment of various autoimmune diseases. Heat shock proteins (HSPs) are a family of proteins known for their roles as molecular chaperones and their involvement in immune regulation. In the context of autoimmune diseases, these preparations are believed to exert therapeutic effects by modulating immune responses, potentially by activating immune regulatory mechanisms and promoting the expansion of T regulatory cells, which are crucial for maintaining immune tolerance and reducing inflammation.

Other names: 胎盘提取热休克蛋白制剂

Targets

TLR2 (Toll-like Receptor 2)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on heat shock protein preparation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on heat shock protein preparation.

Explore the full profile